Literature DB >> 11337310

Surgical management of renal cell carcinoma invading into the liver: radical nephrectomy en bloc with right hepatic lateral sector.

K Johnin1, O Nakai, A Kataoka, S Koizumi, C Dok An, Y Okada, M Makuuchi.   

Abstract

Renal cell carcinoma demonstrates expansive growth and invasion of adjacent structures. Direct liver extension, although uncommon, is a dismal prognostic sign. We propose radical nephrectomy en bloc with right lateral sector (segments 6 and 7) of the liver. The operative procedure was performed in 2 male patients, 61 and 81 years of age, both with renal cell carcinoma and direct hepatic extension. The patients had no evidence of disease at 100 and 57 months after resection. This procedure may help cure selected patients with renal cell carcinoma invading the liver.

Entities:  

Mesh:

Year:  2001        PMID: 11337310     DOI: 10.1016/s0090-4295(01)00939-6

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  3 in total

1.  Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results from a retrospective comparative analysis.

Authors:  Michael D Staehler; Jessica Kruse; Nicolas Haseke; Thomas Stadler; Alexander Roosen; Alexander Karl; Christian G Stief; Karl W Jauch; Christiane J Bruns
Journal:  World J Urol       Date:  2010-05-04       Impact factor: 4.226

2.  Partial nephrectomy and enbloc liver resection using a bipolar radiofrequency device for renal cell carcinoma invading the liver.

Authors:  M Pitchaimuthu; M Pai; N A Habib
Journal:  BMJ Case Rep       Date:  2010-10-28

Review 3.  A safe combined nephrectomy and right lobectomy using the liver hanging maneuver for huge renal cell carcinoma directly invading the right lobe of the liver: report of a case.

Authors:  Masanori Yoshimatsu; Ken Shirabe; Yoshihiro Nagao; Noboru Harada; Hideaki Uchiyama; Tomoharu Yoshizumi; Akinobu Taketomi; Tetsuo Ikeda; Katsunori Tatsugami; Yoshihiko Maehara
Journal:  Surg Today       Date:  2013-09-19       Impact factor: 2.549

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.